Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years
Oncology Research and Treatment · 2020 · 43 (11) · 613-619
DOI: 10.1159/000509519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research and Treatment, online erschienen am 27.08.2020. Verfasst von Jakob Lochner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
The objective of this study was to investigate the prognosis of patients with metastatic soft tissue sarcomas (STS) and to define prognostic indicators for overall survival (OS).
Methods
All patients who were treated at the Sarcoma Unit at the Mannheim University Medical Center between 2010 and 2016 and who developed metastatic disease deriving from a STS were included in this retrospective analysis. OS was investigated using data from clinical records and German registry offices. Clinical and pathological characteristics were recorded and analyzed.
Results
A total number of 212 patients developed metastatic disease from STS during that period. Median OS after first documentation of metastatic disease was 24 months (95% CI 21–33). 1-, 2-, and 5-year OS rates were 70.0% (95% CI 64–77), 49.9% (95% CI 43–58), and 24.8% (95% CI 19–33), respectively. In multivariate analysis, significant predictors for mortality appeared to be gender, age, location and size of the primary tumor, histology, and disease-free interval.
Conclusion
Being treated in a high-volume STS reference center in Germany, patients with metastatic disease could demonstrate an increased OS compared to former analyses. These data can be used as a benchmark for upcoming studies and highlight that further research on treatment strategies in this rare disease is urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.
- Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany, mail@berndkasper.de.
Zitieren
APA
Lochner, J., Menge, F., Vassos, N., Hohenberger, P., & Kasper, B. (2020). Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years. Oncology Research and Treatment, 43(11), 613-619. https://doi.org/10.1159/000509519
Vancouver
Lochner J, Menge F, Vassos N, Hohenberger P, Kasper B. Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years. Oncology Research and Treatment. 2020;43(11):613-619. doi:10.1159/000509519
BibTeX
@article{Lochner2020,
author = {Lochner, Jakob and Menge, Franka and Vassos, Nikolaos and Hohenberger, Peter and Kasper, Bernd},
title = {Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years},
journal = {Oncology Research and Treatment},
year = {2020},
volume = {43},
number = {11},
pages = {613--619},
doi = {10.1159/000509519}
}
EUVIMED